Pathway Drugs
1 known investors
Pathway Drugs provides solutions for self-insured employers, benefits consultants, health plans, and pharmacy benefit managers (PBMs) in the healthcare and drug management sector.
Also known as viaPathway
Investors · 1
Company profile
researched Aug 2026Pathway Drugs, which presents its offering under the name viaPathway on pathwaydrugs.com, addresses the pharmacy benefit and drug management market. Its public web presence consists of a contact page inviting self-insured employers, benefits consultants, health plans or third-party administrators (TPAs), and pharmacy benefit managers (PBMs) to get in touch to learn more, with a form capturing the visitor's role or type of interest among those categories.
▸Full profile — go-to-market
Go-to-market
Prospective customers are engaged through a direct inquiry form on the company website, which segments respondents by role: benefits consultant, employer, health plan or TPA, PBM, TPA, or other.
The company's site directs itself at self-insured employers, benefits consultants, health plans and third-party administrators (TPAs), and pharmacy benefit managers (PBMs).
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 5
primary sources listed
- Pathway Drugspathwaydrugs.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pathway Drugs do?
- Pathway Drugs (viaPathway) works with self-insured employers, benefits consultants, health plans, TPAs and PBMs on drug benefits.
- Who are Pathway Drugs's investors?
- Pathway Drugs's investors include NextGen Venture Partners.